Fingerpaint
Kevin Kish is the current Chief Financial Officer at Fingerpaint Group. Prior to this role, Kevin held various finance positions at companies such as Syneos Health Communications (previously inVentiv Health Communications) and inVentiv Health Advertising. With a strong background in finance and a BA in Accounting, Economic Management, and English from Ohio Wesleyan University, Kevin has a wealth of experience in the industry.
This person is not in any offices
Fingerpaint
3 followers
Fingerpaint, built on a foundation of empathy, at its core is committed to creating and executing meaningful brand experiences that are never paint by number for healthcare providers, care partners, and patients. In 2020, Fingerpaint acquired 1798, a market access and commercialization firm located in La Jolla, Calif., adding to its portfolio of services in support of biopharma customers. The agency also launched Photo 51, a gene therapy consultancy. Fingerpaint was named 2019 Agency of the Year by Med Ad News, and in 2018, it won the Heart Award from Med Ad News for its commitment to philanthropy and social causes. Additionally, it has been on Inc. Magazine’s list of the 5,000 Fastest-Growing Companies for the past eight years.